What is Different About Opioid Dependent Patients Who Smoke?-Recording

Video Transcription

Video Summary

The discussion focuses on opioid use disorders, emphasizing the high smoking rates among those with psychiatric and substance use disorders (PSUD) and how to assist them in quitting smoking. The Substance Abuse and Mental Health Services Administration (SAMHSA) has created the Opioid Response Network (ORN) to provide resources, local consultation, and technical assistance for evidence-based prevention treatment and recovery of opioid and stimulant use disorders. Studies indicate a strong link between smoking and substance use disorders, highlighting nicotine's complex interaction with multiple neurotransmitter systems, making it difficult to quit. This discourse stresses the importance of treating nicotine addiction to prevent relapses in substance use recovery. Despite improvements in tobacco treatment within substance use facilities, comprehensive care, which includes both medications and therapy, remains underused. Nicotine replacement therapies (NRTs) like the patch, gum, and lozenges can help reduce cravings, particularly when used in combination. Furthermore, medications like bupropion and varenicline (Chantix) can enhance quitting success, especially when tailored to individual needs. Addressing nicotine addiction as part of comprehensive substance use disorder treatment can significantly improve long-term recovery outcomes.

Keywords

opioid use disorders

psychiatric disorders

substance use disorders

smoking cessation

Opioid Response Network

nicotine addiction

nicotine replacement therapies

bupropion

varenicline